Brevet US3622615 - TOLYLSULFONYL)-L-ARGININE ESTERS

Référencé par

Brevet citant	Date de dépôt	Date de délivrance	Cessionnaire d'origine	Titre
US3978045	13 août 1974	31 août 1976	Mitsubishi Chemical Industries Ltd.	N.sup.2 -dansyl-L-arginine derivatives, and the pharmaceutically acceptable acid addition salts thereof
US4018913	14 janv. 1976	19 avr. 1977	Mitsubishi Chemical Industries Ltd. Shosuke Okamoto	N.sup.2 -alkoxynaphthalenesulfonyl-L-argininamides and the pharmaceutically acceptable salts thereof
US4018915	5 janv. 1976	19 avr. 1977	Mitsubishi Chemical Industries Ltd. Shosuke Okamoto	N.sup.2 -alkoxynaphthalenesulfonyl-L-argininamides and the pharmaceutically acceptable salts thereof
US4036955	22 juil. 1976	19 juil. 1977	Mitsubishi Chemical Industries Ltd. Shosuke Okamoto	N.sup.2 -naphthalenesulfonyl-L-argininamides and the pharmaceutically acceptable salts thereof
US4041156	6 févr. 1976	9 août 1977	Mitsubishi Chemical Industries Limited	N.sup.2 -alkoxynaphthalenesulfonyl-L-argininamides and the pharmaceutically acceptable salts thereof
US4046876	10 févr. 1976	6 sept. 1977	Mitsubishi Chemical Industries Limited	N.sup.2 -alkoxynaphthalenesulfonyl-L-argininamides and the pharmaceutically acceptable salts thereof
US4049645	29 mars 1976	20 sept. 1977	Mitsubishi Chemical Industries Limited Shosuke Okamoto	N.sup.2 -naphthalenesulfonyl-L-arginine derivatives, and the pharmaceutically acceptable acid addition salts thereof
US4055636	9 déc. 1975	25 oct. 1977	Mitsubishi Chemical Industries Ltd. Shosuke Okamoto	N.sup.2 -alkoxynaphthalenesulfonyl-L-argininamides and the pharmaceutically acceptable salts thereof
US4055651	28 janv. 1976	25 oct. 1977	Mitsubishi Chemical Industries Ltd. Shosuke Okamoto	N.sup.2 -alkoxynaphthalenesulfonyl-L-argininamides and the pharmaceutically acceptable salts thereof
US4062963	29 mars 1976	13 déc. 1977	Mitsubishi Chemical Industries Limited Shosuke Okamoto	N.sup.2 -naphthalenesulfonyl-L-arginine derivatives, and the pharmaceutically acceptable acid addition salts thereof
US4066758	29 mars 1976	3 janv. 1978	Mitsubishi Chemical Industries Limited Shosuke Okamoto	N.sup.2 -naphthalenesulfonyl-L-arginine derivatives, and the pharmaceutically acceptable acid addition salts thereof
US4070457	24 mars 1976	24 janv. 1978	Mitsubishi Chemical Industries Ltd. Shosuke Okamoto	N.sup.2 -naphthalenesulfonyl-L-argininamides and the pharmaceutically acceptable salts thereof
US4072757	19 janv. 1977	7 févr. 1978	Mitsubishi Chemical Industries Limited Shosuke Okamoto	N.sup.2 alkoxynaphthylsulfonyl-L-argininamides and the pharmaceutically acceptable salts thereof
US4073913	19 janv. 1977	14 févr. 1978	Mitsubishi Chemical Industries Limited Shosuke Okamoto	N.sup.2 -arylsulfonyl-L-argininamides and the pharmaceutically acceptable salts thereof
US4073914	11 août 1976	14 févr. 1978	Mitsubishi Chemical Industries Limited Shosuke Okamoto	N.sup.2 -naphthalenesulfonyl-L-argininamides and the pharmaceutically acceptable salts thereof
US4117127	21 oct. 1977	26 sept. 1978	Mitsubishi Chemical Industries Ltd. Shosuke Okamoto	N.sup.2 -Arylsulfonyl-L-argininamides and the pharmaceutically acceptable salts thereof
US4118575	5 sept. 1975	3 oct. 1978	Choay S.A.	Derivatives of para-guanidino-L-phenylalanine and methods of preparing them
US4125619	19 janv. 1977	14 nov. 1978	Mitsubishi Chemical Industries, Ltd. Shosuke Okamoto	N.sup.2 -naphthalenesulfonyl-L-arginine derivatives and the pharmaceutically acceptable acid addition salts thereof
US4139529	31 août 1977	13 févr. 1979	Mitsubishi Chemical Industries Limited Shosuke Okamoto	N.sup.2 -Naphthalenesulfonyl-L-arginine derivatives and the pharmaceutically acceptable acid addition salts thereof
US4227006	1 juin 1976	7 oct. 1980	Mitsubishi Chemical Industries Ltd.	N.sup.2 -Dansyl-L-arginine derivatives, and the pharmaceutically acceptable acid addition salts thereof
US5840733	1 juil. 1996	24 nov. 1998	RedCell, Canada, Inc.	Methods and compositions for producing novel conjugates of thrombin inhibitors and endogenous carriers resulting in anti-thrombins with extended lifetimes
US5942620	1 juil. 1998	24 août 1999	ConjuChem, Inc.	Methods for producing novel conjugates of thrombin inhibitors
US6087375	11 juin 1999	11 juil. 2000	ConjuChem, Inc.	Methods of treating or preventing thromboses
US6277863	22 juin 2000	21 août 2001	Conjuchem, Inc.	Methods and compositions for producing novel conjugates of thrombin inhibitors and endogenous carriers resulting in anti-thrombins with extended lifetimes

Brevets

TOLYLSULFONYL)-L-ARGININE ESTERS

Référencé par